Pionarus Bio, Inc.
1 known investors
Find your way into Pionarus Bio, Inc.
Pionarus develops synthetically produced, precision-designed cannabinoid compounds targeting women's health conditions such as menopause and metabolic disease. The company focuses on pharmaceutical-grade cannabinoid therapies optimized for target selectivity, oral bioavailability, and regulatory clarity.
Investors · 1
Frequently asked questions
- What does Pionarus Bio, Inc. do?
- Pionarus develops synthetically produced, precision-designed cannabinoid compounds targeting women's health conditions such as menopause and metabolic disease. The company focuses on pharmaceutical-grade cannabinoid therapies optimized for target selectivity, oral bioavailability, and regulatory clarity.
- Who are Pionarus Bio, Inc.'s investors?
- Pionarus Bio, Inc.'s investors include Colorado BioScience Association.